Antenatal corticosteroid treatment and neonatal outcomes for infants 501 to 1500 gm in the Vermont-Oxford trials network
- 1 July 1995
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 173 (1) , 275-281
- https://doi.org/10.1016/0002-9378(95)90213-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Antenatal steroids and neonatal outcomes in controlled clinical trials of surfactant replacementAmerican Journal of Obstetrics and Gynecology, 1995
- Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: The NICHD neonatal research networkAmerican Journal of Obstetrics and Gynecology, 1995
- Evidence from multicenter neworks on the current use and effectiveness of antenatal corticosteroids in low birth weight infantsAmerican Journal of Obstetrics and Gynecology, 1995
- Obsevational evidence for the efficacy of antenatal steroids from randomized studies of surfactant replacementAmerican Journal of Obstetrics and Gynecology, 1995
- An assessment of data quality in the Vermont-Oxford Trials Network DatabaseControlled Clinical Trials, 1995
- Effect of Surfactant on Morbidity, Mortality, and Resource Use in Newborn Infants Weighing 500 to 1500 gNew England Journal of Medicine, 1994
- The Vermont-Oxford Trials Network: Very Low Birth Weight Outcomes for 1990Pediatrics, 1993
- Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infantsAmerican Journal of Obstetrics and Gynecology, 1993
- Maternal Glucocorticoid Therapy and Reduced Risk of Bronchopulmonary DysplasiaPediatrics, 1990
- Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gmThe Journal of Pediatrics, 1978